Cerenome Advances CNS Oncology Platform and Trials
Houston, Texas, August 14, 2026 Cerenome, Inc. reported continued progress across its integrated central nervous system (CNS) oncology platform,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Houston, Texas, August 14, 2026 Cerenome, Inc. reported continued progress across its integrated central nervous system (CNS) oncology platform,...
Mumbai, India & Naples, Florida, USA, August 10, 2026 Lupin Limited has announced that it has received U.S. Food...
Seoul, South Korea, August 10, 2026 Seegene Inc. has announced a comprehensive approach to syndromic PCR screening for reproductive...
TOKYO, July 22, 2026 Kirin Holdings Company, Limited and Blackmores Limited have announced the launch of two new Cognizin®...
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has announced a comprehensive Syndromic...
SYDNEY, Australia & INCHEON, South Korea, July 16, 2026 Organon and Samsung Bioepis have expanded their longstanding partnership through...
SALT LAKE CITY, July 20, 2026 ARUP Laboratories has introduced ARUP CLARISPECTâ„¢ Multiple Myeloma MRD by Spectral Flow Cytometry,...
LENEXA, Kan., July 16, 2026 Eurofins Viracor has expanded its immunology testing portfolio with the launch of three new...
IRVINE, Calif., July 15, 2026 Zepto Life Technology has expanded its FungiFlex® molecular diagnostics portfolio with the launch of...
CARLSBAD, California, July 13, 2026 ALZpath, Inc. has announced a major scientific milestone at the Alzheimer’s Association International Conference...
